Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome
Numerous studies have focused on inflammation-related markers to understand COVID-19. In this study, we performed a comparative analysis of spike (S) and nucleocapsid (N) protein-specific IgA, total IgG and IgG subclass response in COVID-19 patients and compared this to their disease outcome. We observed that the SARS-CoV-2 infection elicits a robust IgA and IgG response against the N-terminal (N1) and C-terminal (N3) region of the N protein, whereas we failed to detect IgA antibodies and observed a weak IgG response against the disordered linker region (N2) in COVID-19 patients. N and S protein-specific IgG1, IgG2 and IgG3 response was significantly elevated in hospitalized patients with severe disease compared to outpatients with non-severe disease. IgA and total IgG antibody reactivity gradually increased after the first week of symptoms. Magnitude of RBD-ACE2 blocking antibodies identified in a competitive assay and neutralizing antibodies detected by PRNT assay correlated with disease severity. Generally, the IgA and total IgG response between the discharged and deceased COVID-19 patients was similar. However, significant differences in the ratio of IgG subclass antibodies were observed between discharged and deceased patients, especially towards the disordered linker region of the N protein. Overall, SARS-CoV-2 infection is linked to an elevated blood antibody response in severe patients compared to non-severe patients. Monitoring of antigen-specific serological response could be an important tool to accompany disease progression and improve outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Viruses - 15(2023), 4 vom: 20. Apr. |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 01.05.2023 Date Revised 01.05.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/v15041018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356165736 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356165736 | ||
| 003 | DE-627 | ||
| 005 | 20231226065902.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/v15041018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356165736 | ||
| 035 | |a (NLM)37112998 | ||
| 035 | |a (PII)1018 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salgado, Bárbara Batista |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antigen-Specific Antibody Signature Is Associated with COVID-19 Outcome |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.05.2023 | ||
| 500 | |a Date Revised 01.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Numerous studies have focused on inflammation-related markers to understand COVID-19. In this study, we performed a comparative analysis of spike (S) and nucleocapsid (N) protein-specific IgA, total IgG and IgG subclass response in COVID-19 patients and compared this to their disease outcome. We observed that the SARS-CoV-2 infection elicits a robust IgA and IgG response against the N-terminal (N1) and C-terminal (N3) region of the N protein, whereas we failed to detect IgA antibodies and observed a weak IgG response against the disordered linker region (N2) in COVID-19 patients. N and S protein-specific IgG1, IgG2 and IgG3 response was significantly elevated in hospitalized patients with severe disease compared to outpatients with non-severe disease. IgA and total IgG antibody reactivity gradually increased after the first week of symptoms. Magnitude of RBD-ACE2 blocking antibodies identified in a competitive assay and neutralizing antibodies detected by PRNT assay correlated with disease severity. Generally, the IgA and total IgG response between the discharged and deceased COVID-19 patients was similar. However, significant differences in the ratio of IgG subclass antibodies were observed between discharged and deceased patients, especially towards the disordered linker region of the N protein. Overall, SARS-CoV-2 infection is linked to an elevated blood antibody response in severe patients compared to non-severe patients. Monitoring of antigen-specific serological response could be an important tool to accompany disease progression and improve outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a IgG subclass | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a antibody isotypes | |
| 650 | 4 | |a nucleocapsid | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Immunoglobulin A |2 NLM | |
| 650 | 7 | |a Immunoglobulin M |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 700 | 1 | |a Jordão, Maele Ferreira |e verfasserin |4 aut | |
| 700 | 1 | |a de Morais, Thiago Barros do Nascimento |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Danielle Severino Sena |e verfasserin |4 aut | |
| 700 | 1 | |a Pereira Filho, Ivanildo Vieira |e verfasserin |4 aut | |
| 700 | 1 | |a Salgado Sobrinho, Wlademir Braga |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, Nani Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Dos Santos, Rafaella Oliveira |e verfasserin |4 aut | |
| 700 | 1 | |a Forato, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Barbosa, Priscilla Paschoal |e verfasserin |4 aut | |
| 700 | 1 | |a Toledo-Teixeira, Daniel A |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto, Kerollen Runa |e verfasserin |4 aut | |
| 700 | 1 | |a Correia, Ingrid Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Cordeiro, Isabelle Bezerra |e verfasserin |4 aut | |
| 700 | 1 | |a Souza Neto, Júlio Nino de |e verfasserin |4 aut | |
| 700 | 1 | |a Assunção, Enedina Nogueira de |e verfasserin |4 aut | |
| 700 | 1 | |a Val, Fernando Fonseca Almeida |e verfasserin |4 aut | |
| 700 | 1 | |a Melo, Gisely Cardoso |e verfasserin |4 aut | |
| 700 | 1 | |a Sampaio, Vanderson de Souza |e verfasserin |4 aut | |
| 700 | 1 | |a Monteiro, Wuelton Marcelo |e verfasserin |4 aut | |
| 700 | 1 | |a Granja, Fabiana |e verfasserin |4 aut | |
| 700 | 1 | |a Souza, William M de |e verfasserin |4 aut | |
| 700 | 1 | |a Astolfi Filho, Spartaco |e verfasserin |4 aut | |
| 700 | 1 | |a Proenca-Modena, Jose Luiz |e verfasserin |4 aut | |
| 700 | 1 | |a Lalwani, Jaila Dias Borges |e verfasserin |4 aut | |
| 700 | 1 | |a Lacerda, Marcus Vinícius Guimarães de |e verfasserin |4 aut | |
| 700 | 1 | |a Nogueira, Paulo Afonso |e verfasserin |4 aut | |
| 700 | 1 | |a Lalwani, Pritesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 15(2023), 4 vom: 20. Apr. |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:4 |g day:20 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/v15041018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 4 |b 20 |c 04 | ||